Highlights Atomo Diagnostics Limited

Equities

AT1

AU0000080327

Market Closed - Australian S.E. Other stock markets 01:11:01 24/05/2024 BST			5-day change	1st Jan Change
0.031 ^AUD	0.00%		-3.12%	+40.91%

05-16	Easing US Inflation Boosts Australian Shares to Six-Week High	MT
05-16	Atomo Diagnostics Supports HIV-Self Testing Push of the Australian Federal Government; Shares Surge 19%	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Easing US Inflation Boosts Australian Shares to Six-Week High	05-16	MT
Atomo Diagnostics Supports HIV-Self Testing Push of the Australian Federal Government; Shares Surge 19%	05-16	MT
Atomo Diagnostics Wins AU$570,000 HIV Self-Tests Order	04-15	MT
Atomo Diagnostics Wins Order to Supply AU$970,000 Worth of HIV Self-Tests	03-06	MT
Atomo Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-25	CI
Atomo Diagnostics Expands Footprint of HIV Self-Test Kit	20/10/23	MT
Atomo Diagnostics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	24/08/23	CI
Atomo Diagnostics Signs Deal to Supply HIV Tests to Europe	14/06/23	MT
Atomo Diagnostics Secures Nearly $2 Million Supply Deal for HIV Self-Test in South Africa	05/04/23	MT
Atomo Diagnostics Secures AU$900,000 HIV Self-Tests Order	28/02/23	MT
Atomo Diagnostics Limited Announces Significant Purchase Order for HIV Self-Tests for Europe	27/02/23	CI
Atomo Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2022	22/02/23	CI
Atomo Diagnostics, NG Biotech Sign Commercialization Deal for Rapid Blood-based Pregnancy Tests; Shares Jump 4%	18/01/23	MT
Atomo Diagnostics Limited and NG Biotech Sign New Commercialisation Agreement to Expand the Launch of A Unique Blood Based Rapid Pregnancy Test in Key Global Markets	17/01/23	CI
Atomo Diagnostics Limited Reports Earnings Results for the Full Year Ended June 30, 2022	25/08/22	CI
Atomo Diagnostics Limited Signs Agreement with Hangzhou Alltest Biotech Co., Ltd, for Supply of A Covid-19 1 Rapid Antigen Self-Test in the Australian and New Zealand Markets	22/08/22	CI
Atomo Diagnostics : Quarterly Activity Report - 30 June 2022	28/07/22	PU
Atomo Diagnostics : Quarterly Activity Report - 31 March 2022	27/04/22	PU
Atomo Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2021	21/02/22	CI
Atomo Diagnostics Secures Approval for COVID-19 Antigen Test in New Zealand; Shares Jump 8%	27/01/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Atomo Diagnostics Limited

Equities

AT1

AU0000080327

Highlights

Filters